Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: CALCIUM ACETATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for calcium acetate capsules (667 mg) from Rising Pharma Holdings, Inc., a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium Acetate Capsule 667 mg (calcium acetate)

Snippet

ORIG AP for CALCIUM ACETATE (CALCIUM ACETATE)